TY - JOUR
T1 - Heat intolerance in patients with chronic schizophrenia maintained with antipsychotic drugs
AU - Hermesh, H.
AU - Shiloh, R.
AU - Epstein, Y.
AU - Manaim, H.
AU - Weizman, A.
AU - Munitz, H.
PY - 2000
Y1 - 2000
N2 - Objective: Schizophrenia may be associated with hyperthermic syndromes such as febrile catatonia, neuroleptic malignant syndrome, and heatstroke. The authors hypothesized that an exercise-heat tolerance test would disclose abnormal thermoregulation in schizophrenic patients. Method: Seven male schizophrenic outpatients in remission maintained on depot antipsychotic treatment and eight healthy comparison subjects completed a heat tolerance test that consisted of two 50-minute bouts of walking a motor-driven treadmill at 40xC (relative humidity=40%). Results: A significantly higher rise in rectal and skin temperatures was observed in the patient group. No differences in heart rate, blood pressure, or perspiration were detected. Conclusions: Schizophrenic patients maintained on antipsychotic drugs exhibit impaired heat tolerance. Possible explanations are a reduced ability to convey heat from the body's core to the periphery with or without excessive heat production. The hyperthermic response to the heat tolerance test may reflect a dysfunction associated with schizophrenia, a neuroleptic-induced side effect, or both.
AB - Objective: Schizophrenia may be associated with hyperthermic syndromes such as febrile catatonia, neuroleptic malignant syndrome, and heatstroke. The authors hypothesized that an exercise-heat tolerance test would disclose abnormal thermoregulation in schizophrenic patients. Method: Seven male schizophrenic outpatients in remission maintained on depot antipsychotic treatment and eight healthy comparison subjects completed a heat tolerance test that consisted of two 50-minute bouts of walking a motor-driven treadmill at 40xC (relative humidity=40%). Results: A significantly higher rise in rectal and skin temperatures was observed in the patient group. No differences in heart rate, blood pressure, or perspiration were detected. Conclusions: Schizophrenic patients maintained on antipsychotic drugs exhibit impaired heat tolerance. Possible explanations are a reduced ability to convey heat from the body's core to the periphery with or without excessive heat production. The hyperthermic response to the heat tolerance test may reflect a dysfunction associated with schizophrenia, a neuroleptic-induced side effect, or both.
UR - http://www.scopus.com/inward/record.url?scp=0033838993&partnerID=8YFLogxK
U2 - 10.1176/appi.ajp.157.8.1327
DO - 10.1176/appi.ajp.157.8.1327
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 10910799
AN - SCOPUS:0033838993
SN - 0002-953X
VL - 157
SP - 1327
EP - 1329
JO - American Journal of Psychiatry
JF - American Journal of Psychiatry
IS - 8
ER -